Translation of "Summary score" in German
																						Greater
																											improvements
																											at
																											Week
																											12
																											from
																											baseline
																											compared
																											to
																											placebo
																											were
																											demonstrated
																											in
																											skin-specific
																											health-related
																											quality
																											of
																											life,
																											as
																											measured
																											by
																											the
																											Dermatology
																											Life
																											Quality
																											Index
																											(DLQI;
																											Studies
																											HS-I
																											and
																											HS-II),
																											patient
																											global
																											satisfaction
																											with
																											medication
																											treatment
																											as
																											measured
																											by
																											the
																											Treatment
																											Satisfaction
																											Questionnaire
																											-
																											medication
																											(TSQM;
																											Studies
																											HS-I
																											and
																											HS-II),
																											and
																											physical
																											health
																											as
																											measured
																											by
																											the
																											physical
																											component
																											summary
																											score
																											of
																											the
																											SF-36
																											(Study
																											HS-I).
																		
			
				
																						Studie
																											HS-I
																											und
																											HS-II)
																											gemessenen
																											allgemeinen
																											Zufriedenheit
																											der
																											Patienten
																											mit
																											der
																											medikamentösen
																											Behandlung
																											und
																											der
																											anhand
																											des
																											Physical
																											Component
																											Summary
																											Score
																											des
																											SF-36-Fragebogens
																											(Studie
																											HS-I)
																											gemessenen
																											körperlichen
																											Gesundheit
																											festgestellt.
															 
				
		 ELRC_2682 v1
			
																						Greater
																											improvements
																											at
																											week
																											12
																											from
																											baseline
																											compared
																											to
																											placebo
																											were
																											demonstrated
																											in
																											skin-specific
																											health-related
																											quality
																											of
																											life,
																											as
																											measured
																											by
																											the
																											Dermatology
																											Life
																											Quality
																											Index
																											(DLQI;
																											Studies
																											HS-I
																											and
																											HS-II),
																											patient
																											global
																											satisfaction
																											with
																											medication
																											treatment
																											as
																											measured
																											by
																											the
																											Treatment
																											Satisfaction
																											Questionnaire
																											-
																											medication
																											(TSQM;
																											Studies
																											HS-I
																											and
																											HS-II),
																											and
																											physical
																											health
																											as
																											measured
																											by
																											the
																											physical
																											component
																											summary
																											score
																											of
																											the
																											SF-36
																											(Study
																											HS-I).
																		
			
				
																						Studie
																											HS-I
																											und
																											HS-II)
																											gemessenen
																											allgemeinen
																											Zufriedenheit
																											der
																											Patienten
																											mit
																											der
																											medikamentösen
																											Behandlung
																											und
																											der
																											anhand
																											des
																											Physical
																											Component
																											Summary
																											Score
																											des
																											SF-36-Fragebogens
																											(Studie
																											HS-I)
																											gemessenen
																											körperlichen
																											Gesundheit
																											festgestellt.
															 
				
		 ELRC_2682 v1
			
																						Greater
																											improvements
																											at
																											week
																											12
																											from
																											baseline
																											compared
																											to
																											placebo
																											were
																											demonstrated
																											in
																											skinspecific
																											health-related
																											quality
																											of
																											life,
																											as
																											measured
																											by
																											the
																											Dermatology
																											Life
																											Quality
																											Index
																											(DLQI;
																											Studies
																											HS-I
																											and
																											HS-II),
																											patient
																											global
																											satisfaction
																											with
																											medication
																											treatment
																											as
																											measured
																											by
																											the
																											Treatment
																											Satisfaction
																											Questionnaire
																											-
																											medication
																											(TSQM;
																											Studies
																											HS-I
																											and
																											HS-II),
																											and
																											physical
																											health
																											as
																											measured
																											by
																											the
																											physical
																											component
																											summary
																											score
																											of
																											the
																											SF-36
																											(study
																											HS-I).
																		
			
				
																						Studie
																											HS-I
																											und
																											HS-II)
																											gemessenen
																											allgemeinen
																											Zufriedenheit
																											der
																											Patienten
																											mit
																											der
																											medikamentösen
																											Behandlung
																											und
																											der
																											anhand
																											des
																											Physical
																											Component
																											Summary
																											Score
																											des
																											SF-36-Fragebogens
																											(Studie
																											HS-I)
																											gemessenen
																											körperlichen
																											Gesundheit
																											festgestellt.
															 
				
		 ELRC_2682 v1
			
																						Greater
																											improvements
																											at
																											week
																											12
																											from
																											baseline
																											compared
																											to
																											placebo
																											were
																											demonstrated
																											in
																											skinspecific
																											health-related
																											quality
																											of
																											life,
																											as
																											measured
																											by
																											the
																											Dermatology
																											Life
																											Quality
																											Index
																											(DLQI;
																											Studies
																											HS-I
																											and
																											HS-II),
																											patient
																											global
																											satisfaction
																											with
																											medication
																											treatment
																											as
																											measured
																											by
																											the
																											Treatment
																											Satisfaction
																											Questionnaire-medication
																											(TSQM;
																											Studies
																											HS-I
																											and
																											HS-II),
																											and
																											physical
																											health
																											as
																											measured
																											by
																											the
																											physical
																											component
																											summary
																											score
																											of
																											the
																											SF-36
																											(study
																											HS-I).
																		
			
				
																						Studie
																											HS-I
																											und
																											HS-II)
																											gemessenen
																											allgemeinen
																											Zufriedenheit
																											der
																											Patienten
																											mit
																											der
																											medikamentösen
																											Behandlung
																											und
																											der
																											anhand
																											des
																											Physical
																											Component
																											Summary
																											Score
																											des
																											SF-36-Fragebogens
																											(Studie
																											HS-I)
																											gemessenen
																											körperlichen
																											Gesundheit
																											festgestellt.
															 
				
		 ELRC_2682 v1
			
																						Here,
																											you
																											find
																											the
																											summary
																											of
																											the
																											scores
																											of
																											the
																											Mosquitos.
																		
			
				
																						Hier
																											findet
																											ihr
																											die
																											Zusammenfassung
																											der
																											Einsatzbewertung
																											der
																											Mosquitos.
															 
				
		 ParaCrawl v7.1
			
																						In
																											study
																											I,
																											improvements
																											in
																											the
																											physical
																											and
																											mental
																											component
																											summary
																											scores
																											of
																											the
																											SF-36
																											were
																											also
																											significant
																											compared
																											to
																											placebo.
																		
			
				
																						In
																											Studie
																											I
																											verbesserten
																											sich
																											die
																											Summenwerte
																											der
																											körperlichen
																											und
																											mentalen
																											SF-36-Komponenten
																											im
																											Vergleich
																											zu
																											Placebo
																											ebenfalls
																											signifikant.
															 
				
		 ELRC_2682 v1
			
																						In
																											Study
																											I,
																											improvements
																											in
																											the
																											physical
																											and
																											mental
																											component
																											summary
																											scores
																											of
																											the
																											SF-36
																											were
																											also
																											significant
																											compared
																											to
																											placebo.
																		
			
				
																						In
																											Studie
																											I
																											verbesserten
																											sich
																											die
																											Summenwerte
																											der
																											körperlichen
																											und
																											mentalen
																											SF-36-
																											Komponenten
																											im
																											Vergleich
																											zu
																											Placebo
																											ebenfalls
																											signifikant.
															 
				
		 EMEA v3
			
																						In
																											Psoriasis
																											Study
																											1,
																											improvements
																											in
																											nail
																											psoriasis
																											(Nail
																											Psoriasis
																											Severity
																											Index),
																											in
																											the
																											physical
																											and
																											mental
																											component
																											summary
																											scores
																											of
																											the
																											SF-36
																											and
																											in
																											the
																											Itch
																											Visual
																											Analogue
																											Scale
																											(VAS)
																											were
																											also
																											significant
																											in
																											each
																											ustekinumab
																											treatment
																											group
																											compared
																											with
																											placebo.
																		
			
				
																						In
																											der
																											Psoriasis-Studie
																											1
																											waren
																											in
																											jeder
																											Ustekinumab-Behandlungsgruppe
																											Verbesserungen
																											der
																											Nagel-Psoriasis
																											(Nail
																											Psoriasis
																											Severity
																											Index),
																											in
																											den
																											Physical
																											and
																											Mental
																											Component
																											Summary
																											Scores
																											des
																											SF-36
																											und
																											in
																											der
																											Itch-Visuelle
																											Analog-Skala
																											(VAS)
																											im
																											Vergleich
																											zu
																											Placebo
																											ebenfalls
																											signifikant.
															 
				
		 EMEA v3
			
																						Likewise,
																											the
																											Browserscope
																											summary
																											scores,
																											which
																											track
																											functionality
																											for
																											web
																											developers,
																											include
																											three
																											versions
																											of
																											Chrome,
																											15
																											through
																											17,
																											with
																											identical
																											overall
																											scores
																											of
																											87/100
																											for
																											each
																											one.
																		
			
				
																						Ebenfalls,
																											die
																											Profilers
																											Zusammenfassung
																											Noten,
																											die
																											Spur
																											Funktionalität
																											für
																											Web-Entwickler,
																											gehören
																											drei
																											Versionen
																											von
																											Chrome,
																											15
																											durch
																											17,
																											identisch
																											mit
																											der
																											Gesamtnote
																											87/100
																											für
																											jeden.
															 
				
		 ParaCrawl v7.1